NR1I2 and COVID-19: In conclusion, we provided in-depth insights to understand the mechanism underlying DPTS-induced liver injury (Figure 6): PXR regulation, associated with inflammation-drug and drug-drug interactions, mediated DILI in pharmacologic treatments for COVID-19.